We performed a drug screen with 140 epigenetically active compounds using the Smarcb1-negative murine PTCL cell line T15 as an in vitro model (Supplementary Data S13). Here, SMARCB1 is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.